GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NKY Medical Holdings Ltd (SZSE:300109) » Definitions » ROC (Joel Greenblatt) %

NKY Medical Holdings (SZSE:300109) ROC (Joel Greenblatt) % : 32.98% (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is NKY Medical Holdings ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. NKY Medical Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 32.98%.

The historical rank and industry rank for NKY Medical Holdings's ROC (Joel Greenblatt) % or its related term are showing as below:

SZSE:300109' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 10.45   Med: 22.36   Max: 42.33
Current: 39.34

During the past 13 years, NKY Medical Holdings's highest ROC (Joel Greenblatt) % was 42.33%. The lowest was 10.45%. And the median was 22.36%.

SZSE:300109's ROC (Joel Greenblatt) % is ranked better than
83.47% of 1065 companies
in the Drug Manufacturers industry
Industry Median: 7.85 vs SZSE:300109: 39.34

NKY Medical Holdings's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 15.60% per year.


NKY Medical Holdings ROC (Joel Greenblatt) % Historical Data

The historical data trend for NKY Medical Holdings's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKY Medical Holdings ROC (Joel Greenblatt) % Chart

NKY Medical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.36 12.29 35.07 39.77 42.33

NKY Medical Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.04 57.67 55.30 17.28 32.98

Competitive Comparison of NKY Medical Holdings's ROC (Joel Greenblatt) %

For the Drug Manufacturers - General subindustry, NKY Medical Holdings's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NKY Medical Holdings's ROC (Joel Greenblatt) % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NKY Medical Holdings's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where NKY Medical Holdings's ROC (Joel Greenblatt) % falls into.



NKY Medical Holdings ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(344.13 + 309.802 + 122.399) - (373.554 + 0 + 25.6)
=377.177

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(371.638 + 281.905 + 120.975) - (331.724 + 0 + 31.388)
=411.406

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of NKY Medical Holdings for the quarter that ended in Mar. 2024 can be restated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=576.096/( ( (1316.791 + max(377.177, 0)) + (1387.804 + max(411.406, 0)) )/ 2 )
=576.096/( ( 1693.968 + 1799.21 )/ 2 )
=576.096/1746.589
=32.98 %

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NKY Medical Holdings  (SZSE:300109) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


NKY Medical Holdings ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of NKY Medical Holdings's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


NKY Medical Holdings (SZSE:300109) Business Description

Traded in Other Exchanges
N/A
Address
No.9 Zhongshan Road, Boai county, Jiaozuo, Henan, CHN, 454450
NKY Medical Holdings Ltd develops and manufactures polyvinylpyrrolidone (PVP) series products in China. Its products can be used in Pharmaceutical accessories, hair gel, wine products stabilizer, water treatment, glue stick, and oral care products.

NKY Medical Holdings (SZSE:300109) Headlines

No Headlines